- Bupa Platinum consultant
-
Fee assured
-
Awaiting
verification
- Open Referral network
Specialises in
- Lung
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Rob Stevenson qualified in medicine in 2005 at Leicester-Warwick medical school and then trained to qualify in general medicine in 2008. He went on to obtain his Fellowship in Clinical Oncology in 2013. He trained within the West Midlands and has a special interest in Uro-oncology (prostate, Kidney and bladder cancer) and lung cancer.
In 2014 Rob was appointed as a Consultant Clinical Oncologist at the Queen Elizabeth hospital in Birmingham. He was involved in the development of Stereotactic Radiotherapy for early stage lung cancer at the QE and has introduced concurrent radiotherapy for stage 3 lung cancer at UHB. He also manages patients with prostate, kidney and bladder cancer.
Rob is involved in teaching and is an accredited by the GMC as a trainer and educational supervisor. He also regularly lectures at the University of Birmingham on their Oncology MSc course.
He is also involved in Research and has been a Principal investigator on several National clinical trials and a co-investigator on numerous others. He is also widely published in National and International journals.
Rob was the Radiotherapy Service lead for University Hospitals Birmingham between 2018 and 2020, and has been the Radiotherapy lead for West Midlands since January 2019.
Areas of interest
Bladder cancer treatment; Chemotherapy; Hormone therapy treatment; Kidney cancer treatment; Lung cancer treatment; Prostate cancer treatment; Prostate cancer treatment; Radiotherapy cancer treatment; Targeted therapy; Testicular cancer
Medical secretaries
- Sophie Randell
- Medmin Services Ltd 320 Hagley Road West Oldbury B68 0NP
- 0121 716 9046
- s.randell@medmin.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (1-5)